<- Go Home
Bumrungrad Hospital Public Company Limited
Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. It operates allergy, arrhythmia, behavioral health, breast, home service, heart valve, robotic surgery, rehabilitation, children's, colorectal surgery, complex coronary artery intervention, cornea transplant, dental, diagnostic, dialysis, digestive disease, ear, nose, throat, emergency, endocrinology, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopedics, perinatal, plastic surgery, pulmonary, refractive surgery, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, comprehensive sleep, IVF, hearing and balance, medical, memory, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, vaccine clinics. In addition, it provides spine institute, diagnostic radiology and nuclear medicine, esperance, heart institute, intensive care unit, neurocritical care, nutrition services, pharmacy services, and preventive genomics and integrative medicine services. Further, the company offers clinical research; hospital consulting and management; healthcare personnel development and training; healthcare referral; and digital platform services. Additionally, it is involved in the distribution of pharmaceutical and medical goods in specialized stores; development of software for healthcare services; holding of real estate assets; and manufacture and sale of vitamin supplements. Bumrungrad Hospital Public Company Limited was founded in 1975 and is based in Bangkok, Thailand.
Market Cap
THB 218.6B
Volume
2.7M
Cash and Equivalents
THB 3.9B
EBITDA
THB 10.1B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
THB 13.4B
Profit Margin
50.95%
52 Week High
THB 284.00
52 Week Low
THB 212.00
Dividend
1.87%
Price / Book Value
8.66
Price / Earnings
31.39
Price / Tangible Book Value
8.88
Enterprise Value
THB 208.0B
Enterprise Value / EBITDA
20.62
Operating Income
THB 9.1B
Return on Equity
32.51%
Return on Assets
20.30
Cash and Short Term Investments
THB 11.1B
Debt
THB 138.4M
Equity
THB 25.6B
Revenue
THB 26.2B
Unlevered FCF
THB 4.9B
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium